{"slug":"semax-insomnia","verification":{"valid":true,"entries":2,"head":"f928bdc9fb6c81e27aafbc0f8774e7fe65da41413ddb4c0ea113e588f1f0865d"},"energy":{"passes":2,"tokens_in":21472,"tokens_out":2620,"tokens_total":24092,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"f928bdc9fb6c81e27aafbc0f8774e7fe65da41413ddb4c0ea113e588f1f0865d"},"provenance":[{"ts":"2026-06-30T00:09:04.219Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: Semax for Insomnia\nSlug: semax-insomnia\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_focus\",\"condition\":null,\"condition_key\":null,\"primary_peptide\":null,\"peptides_in_scope\":[{\"id\":\"semax\",\"name\":\"Semax\"}],\"drugs_in_scope\":[],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"semax\",\"name\":\"Semax\",\"section_title\":\"Why Semax might help you\",\"layer\":\"neural / cognitive\",\"steps\":[\"**What keeps failing:** BDNF decline, stimulant-induced neuro stress, cognitive fatigue after dopamine load.\",\"**What Semax is studied to do:** Studied for BDNF and neural support — building connections, not sedating symptoms.\",\"**Therefore for you:** If that layer is part of your problem, Semax is discussed because it targets repair (neural / cognitive) — not because it masks pain.\"],\"prose\":\"1. **What keeps failing:** BDNF decline, stimulant-induced neuro stress, cognitive fatigue after dopamine load.\\n2. **What Semax is studied to do:** Studied for BDNF and neural support — building connections, not sedating symptoms.\\n3. **Therefore for you:** If that layer is part of your problem, Semax is discussed because it targets repair (neural / cognitive) — not because it masks pain.\"}],\"drug_chains\":[],\"stimulant_chains\":[],\"stack_together\":\"Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers","response":"{\"slug\":\"semax-insomnia\",\"title\":\"Semax for Insomnia: Evidence-Graded Review\",\"body\":\"## What's breaking down\\n\\nInsomnia often involves disrupted neural repair processes. BDNF levels can drop under chronic stress or cognitive load, limiting the brain's ability to form and maintain connections overnight. An ACTH fragment like Semax is studied mainly for upregulating BDNF and supporting attention and memory recovery in specific models, not for direct sedation.\\n\\nIf neural plasticity pathways are part of the picture, the discussion centers on whether targeted support there could aid recovery rather than simply suppressing wakefulness signals.\\n\\n## Why Semax might help you\\n\\n1. What keeps failing: BDNF decline and neural stress responses that interfere with the brain's overnight consolidation and repair cycles.\\n2. What Semax is studied to do: Increase BDNF protein and mRNA in rat hippocampus and basal forebrain, alongside effects on attention in small human pilots.\\n3. Therefore for you: If your insomnia links to cognitive fatigue or reduced neuroplasticity rather than pure hyperarousal, Semax enters the conversation because it is researched for repair-layer support, not because it acts as a sleep mask.\\n\\n## How these fit together\\n\\nSingle-compound focus. Semax targets the neural/cognitive layer. Any other approaches would address separate layers such as inflammation or direct sleep architecture if part of a broader profile.\\n\\n## What the evidence actually shows\\n\\nNo dedicated human clinical trials exist that test Semax specifically as a treatment for insomnia (human tier: none found).\\n\\nPreclinical tier: Rat studies demonstrate Semax binds sites in the basal forebrain and raises BDNF protein levels within hours after intranasal dosing at 50–250 µg/kg. One study showed a 1.4-fold BDNF increase in hippocampus plus elevated trkB phosphorylation and improved conditioned avoidance performance (Dolotov et al., 2006, rat model).\\n\\nAnother rat study linked Semax to ","tokens_in":21472,"tokens_out":2620,"cost":0,"prev":"genesis","hash":"de2a15fd29daf4ce9020a36a57384d536a6956c154d36a3bd99ca8cb580927ad"},{"ts":"2026-07-17T02:41:54.896Z","model":"owner","action":"voxel_divide","prompt":"","input":"semax-insomnia","response":"23 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"de2a15fd29daf4ce9020a36a57384d536a6956c154d36a3bd99ca8cb580927ad","hash":"f928bdc9fb6c81e27aafbc0f8774e7fe65da41413ddb4c0ea113e588f1f0865d"}]}